News

Health and Me on MSN2d
FDA Mandates ADHD Drug Labels To Warn Of Weight Loss Risk
The FDA now requires ADHD extended-release drug labels to warn of weight loss risks in children under 6, urging monitoring ...
Fierce Pharma2d
Regulatory tracker: Merck nabs FDA priority review in bid to soup up Winrevair’s label
Welcome to Fierce Pharma's regulatory tracker for the second half of 2025. | In this tracker, Fierce Pharma is recording the ...
Physician's Weekly2d
FDA Will Now Require Labeling of ADHD Medication to Indicate Weight Loss Risk
The U.S. Food and Drug Administration is revising the labeling of all extended-release attention-deficit/hyperactivity ...
US FDA to revise ADHD stimulants labels to warn of weight loss risk in children under 6
The U.S. Food and Drug Administration said on Monday it is revising the labeling of all extended-release stimulants used to ...
MPR1d
FDA Approves Updated Label for Amyloid PET Imaging Agent Amyvid
The Food and Drug Administration (FDA) has approved an updated label for Amyvid (florbetapir F 18 injection) to support Alzheimer disease diagnosis in patients.
Becker's Hospital Review3d
FDA revises ADHD medication label to note weight loss risk
The FDA now requires updated labeling for all extended-release stimulant medications used to treat attention deficit hyperactivity disorder, warning of increased risk of weight loss and other side ...
South Florida drug company recalls 3 eye drugs that might not be sterile
A South Florida drug maker recalled 199,584 bottles of three ophthalmic solutions because of a “lack of assurance on ...
Fierce Pharma8d
Pfizer's hemophilia drug Hympavzi notches phase 3 win as pharma eyes label expansion
Approved eight months ago for a certain class of patients with both hemophilia A or B, Pfizer’s Hympavzi has now shown its ...